Database tracks toxic side effects of pharmaceuticals

December 5, 2013

Sometimes the cure can be worse than the disease. Pharmaceutical drugs are known for their potential side effects, and an important aspect of personalized medicine is to tailor therapies to individuals to reduce the chances of adverse events. Now researchers from North Carolina State University have updated an extensive toxicology database so that it can be used to track information about therapeutic drugs and their unintentional toxic effects.

"Environmental science actually shares a common goal with drug makers: to improve the prediction of chemical toxicity," says Dr. Allan Peter Davis, lead author of a paper on the work and the biocuration project manager of the Comparative Toxicogenomics Database (CTD) in NC State's Department of Biological Sciences.

The scientific literature contains vast information about the adverse effects of therapeutic drugs. But collecting, organizing and making sense of that published information is a daunting task. NC State's CTD team, which historically focused on environmental chemicals, read and coded more than 88,000 scientific papers for this effort.

It took the CTD team one year to efficiently extract information from those 88,000 papers about therapeutic drugs and their involvement in toxic endpoints, such as hypertension, seizures, kidney failure and liver disease. "The project quickly added lots of new data that complements environmental toxicity," says Davis.

The results include more than 250,000 statements collected from seven decades' worth of scientific articles. Putting the data into the CTD framework helps investigators develop and test hypotheses about how drugs might cause adverse events.

"Coding the information in a structured format was key," insists Davis. "This allowed it to be combined with other data to make novel predictions." For example, the drug bortezomib is used to treat certain types of cancer, but it also causes unintended nerve damage in some patients. By linking the data, CTD was able to connect the dots and find genes that that may be key to connecting the drug and the possibility of nerve damage.

"Investigators can now test and validate which genes might be critical to the drug-induced event," explains Davis. "This could be useful in gene-testing patients to tailor the correct medicine or it could help design future therapeutics by alerting safety researchers to avoid those pathways and potential toxic outcomes."

The CTD group also designed a new phenotype module. In this context, phenotypes are events that happen in a cell or system before the toxicity or full-blown disease is recognized at the clinical level. Drugs can affect phenotypes as well as diseases. Independently coding drug-disease and drug-phenotype interactions from the literature and then storing them in the same database allows the system to connect certain phenotypes to diseases, based upon their shared drugs. These connections may allow scientists to resolve, and ultimately prevent, how chemicals – from the environment or from the medicine cabinet – cause toxicity.

More information:
The paper, "A CTD-Pfizer collaboration: manual curation of 88,000 scientific articles text mined for drug-disease and drug-phenotype interactions," is published online in the journal Database.

Related Stories

Keeping up with current scientific literature is a daunting task, considering that hundreds to thousands of papers are published each day. Now researchers from North Carolina State University have developed a computer program ...

New classes of therapeutic antisense oligonucleotides can have toxic effects on the liver. A novel machine learning-based approach used to predict the hepatotoxic potential of an antisense drug based on its chemical sequence ...

Using the Food and Drug Administration's Adverse Event Reporting System (FAERS), a hospital electronic health records database, and an animal model, a team of researchers at the Icahn School of Medicine at Mount Sinai report ...

The three-dimensional structures of proteins determine how, when and where they bind to drugs and other compounds. In 2012 alone, thousands of structures like this were resolved. Now this mass of information needs to be translated ...

Researchers at Washington University School of Medicine in St. Louis have created a massive online database that matches thousands of genes linked to cancer and other diseases with drugs that target those genes. Some of the ...

(Phys.org) —Cylindrical shaped nanoparticles are seven times more deadly than traditional spherical ones when delivering drugs to breast cancer cells, an international team of researchers has discovered.

Persistent pain is common among the nearly 4 million Americans who arrive each year at hospital emergency departments (EDs) after car crashes. A new study in the journal Pain that compared the two most common pain-relief ...

(HealthDay)—Among federal employees who review new cancer-drug applications for the U.S. Food and Drug Administration, about half who leave to work elsewhere end up working for the industry they once regulated.

0 comments

Please sign in to add a comment.
Registration is free, and takes less than a minute.
Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.